Determinants of soluble CD23 antigen levels in hemodialysis patients: effect of 1.25 dihydroxyvitamin D3 and recombinant human erythropoietin treatment.

Source:http://linkedlifedata.com/resource/pubmed/id/10543325

Download in:

View as

General Info

PMID
10543325